Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
15.62
+0.31 (2.02%)
At close: Dec 5, 2025, 4:00 PM EST
15.71
+0.09 (0.58%)
After-hours: Dec 5, 2025, 7:20 PM EST
Aurinia Pharmaceuticals Employees
Aurinia Pharmaceuticals had 130 employees as of December 31, 2024. The number of employees decreased by 170 or -56.67% compared to the previous year.
Employees
130
Change (1Y)
-170
Growth (1Y)
-56.67%
Revenue / Employee
$2,044,677
Profits / Employee
$598,746
Market Cap
2.06B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AUPH News
- 3 days ago - Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? - The Motley Fool
- 4 weeks ago - Aurinia Pharmaceuticals Inc. (AUPH) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress - Business Wire
- 4 weeks ago - Wall Street Breakfast Podcast: FDA Executive Controversy - Seeking Alpha
- 4 weeks ago - Aurinia Pharmaceuticals to Report Financial Results for the Three and Nine Months Ended September 30, 2025 and Provide Update on Recent Business Progress on November 4, 2025 - Business Wire
- 6 weeks ago - Aurinia Pharmaceuticals: Lupkynis Growth And AUR200 Pipeline Justify Buy Rating - Seeking Alpha
- 7 weeks ago - Aurinia Announces Upcoming Presentations of New Data on LUPKYNIS® at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025 - Business Wire
- 2 months ago - Aurinia Responds to Now Retracted LinkedIn Post - Business Wire